{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:09:34Z","timestamp":1794492574688,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T00:00:00Z","timestamp":1579305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011614","name":"University of Kelaniya","doi-asserted-by":"publisher","award":["RP\/03\/SR\/02\/06\/02\/2016"],"award-info":[{"award-number":["RP\/03\/SR\/02\/06\/02\/2016"]}],"id":[{"id":"10.13039\/501100011614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005920","name":"Organization for Women in Science for the Developing World","doi-asserted-by":"publisher","award":["4500384850"],"award-info":[{"award-number":["4500384850"]}],"id":[{"id":"10.13039\/501100005920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008982","name":"National Science Foundation","doi-asserted-by":"publisher","award":["RG\/2015\/BT\/02"],"award-info":[{"award-number":["RG\/2015\/BT\/02"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Dengue presents a wide clinical spectrum. Most patients recover following a self-limiting non-severe clinical course. A small proportion of patients progress to severe disease, mostly characterized by plasma leakage with or without hemorrhage. Early symptoms of severe dengue (SD) are similar to those of non-severe dengue fever (DF). Severe symptoms manifest after 3\u20135\u2009days of fever, which can be life threatening due to lack of proper medications and inability to distinguish severe cases during the early stages. Early prediction of SD in patients with no warning signs who may later develop severe infection is very important for proper disease management to alleviate related complications and mortality. microRNA are small non-coding RNA molecules that regulate post-transcriptional gene expression. Due to the remarkable stability and the role of microRNA in gene expression, altered expression of microRNA was evaluated to explore clinically relevant prognostic markers of severe dengue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The relative expression of microRNA hsa-let-7e (let-7e), hsa-miR-30b-5p (miR-30b), hsa-miR-30e-3p (miR-30e), hsa-miR-33a (miR-33a), and hsa-miR-150-5p (miR-150) and several putative target genes in peripheral blood cells (PBC) collected from 20 DF and 20 SD positive patients within 4 days from fever onset was evaluated by quantitative reverse transcription PCR (qRT-PCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      miR-150 showed significant (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) up regulation in PBC of SD patients compared to DF patients during the acute phase of infection. Expression of enhancer of zeste homolog 2 (EZH2) was significantly (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01) down regulated indicating that genes involved in epigenetic regulation are also differentially expressed in SD patients during the early stage of infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Differential expression of microRNA miR-150 and the putative target gene EZH2 may serve as reliable biomarkers of disease severity during early stages of dengue infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12929-020-0620-z","type":"journal-article","created":{"date-parts":[[2020,1,18]],"date-time":"2020-01-18T13:02:15Z","timestamp":1579352535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Differential expression of microRNA, miR-150 and enhancer of zeste homolog 2 (EZH2) in peripheral blood cells as early prognostic markers of severe forms of dengue"],"prefix":"10.1186","volume":"27","author":[{"given":"Harsha","family":"Hapugaswatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pubudu","family":"Amarasena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjan","family":"Premaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kapila N.","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-3075","authenticated-orcid":false,"given":"Nimanthi","family":"Jayathilaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,18]]},"reference":[{"issue":"2","key":"620_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S1473-3099(18)30023-9","volume":"18","author":"Editorial","year":"2018","unstructured":"Editorial. The dengue vaccine dilemma. Lancet Infect Dis. 2018;18(2):123.","journal-title":"Lancet Infect Dis"},{"key":"620_CR2","unstructured":"World Health Organization (WHO) and the Special Programme for Research and Tropical Diseases (TDR). Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: WHO; 2009. https:\/\/apps.who.int\/iris\/handle\/10665\/44188. New Edition: Accessed 02 Sept 2019"},{"issue":"1","key":"620_CR3","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev-immunol-031210-101315","volume":"29","author":"BR Murphy","year":"2011","unstructured":"Murphy BR, Whitehead SS. Immune response to dengue virus and prospects for a vaccine. Annu Rev Immunol. 2011;29(1):587\u2013619.","journal-title":"Annu Rev Immunol"},{"issue":"5\u20136","key":"620_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cimid.2007.05.010","volume":"30","author":"I Kurane","year":"2007","unstructured":"Kurane I. Dengue hemorrhagic fever with special emphasis on immunopathogenesis. Comp Immunol Microbiol Infect Dis. 2007;30(5\u20136):329\u201340.","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"3","key":"620_CR5","doi-asserted-by":"publisher","first-page":"e967","DOI":"10.1371\/journal.pntd.0000967","volume":"5","author":"A Fox","year":"2011","unstructured":"Fox A, Le NM, Simmons CP, Wolbers M, Wertheim HF, Pham TK, Tran TH, Trinh TM, Nguyen TL, Nguyen VT, et al. Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis. 2011;5(3):e967.","journal-title":"PLoS Negl Trop Dis"},{"key":"620_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijid.2013.10.012","volume":"19","author":"PDNN Sirisena","year":"2014","unstructured":"Sirisena PDNN, Noordeen F. Evolution of dengue in Sri Lanka-changes in the virus, vector, and climate. Int J Infect Dis. 2014;19:6\u201312.","journal-title":"Int J Infect Dis"},{"issue":"16","key":"620_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1056\/NEJM199904223401608","volume":"340","author":"HH Balfour","year":"1999","unstructured":"Balfour HH. Antiviral drugs. N Engl J Med. 1999;340(16):1255\u201368.","journal-title":"N Engl J Med"},{"issue":"5","key":"620_CR8","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/AAC.01148-08","volume":"53","author":"Q-Y Wang","year":"2009","unstructured":"Wang Q-Y, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, et al. A small-molecule dengue virus entry inhibitor. Antimicrob Agents Chemother. 2009;53(5):1823\u201331.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"620_CR9","doi-asserted-by":"publisher","first-page":"e1002627","DOI":"10.1371\/journal.ppat.1002627","volume":"8","author":"AG Schmidt","year":"2012","unstructured":"Schmidt AG, Lee K, Yang PL, Harrison SC. Small-molecule inhibitors of dengue-virus entry. PLoS Pathog. 2012;8(4):e1002627.","journal-title":"PLoS Pathog"},{"issue":"8","key":"620_CR10","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1086\/502630","volume":"193","author":"CL Medin","year":"2006","unstructured":"Medin CL, Rothman AL. Cell type-specific mechanisms of interleukin-8 induction by dengue virus and differential response to drug treatment. J Infect Dis. 2006;193(8):1070\u20137.","journal-title":"J Infect Dis"},{"issue":"12","key":"620_CR11","doi-asserted-by":"publisher","first-page":"e51089","DOI":"10.1371\/journal.pone.0051089","volume":"7","author":"AC Koishi","year":"2012","unstructured":"Koishi AC, Zanello PR, Bianco \u00c9M, Bordignon J, Nunes Duarte dos Santos C. Screening of dengue virus antiviral activity of marine seaweeds by an In Situ enzyme-linked immunosorbent assay. PLoS One. 2012;7(12):e51089.","journal-title":"PLoS One"},{"issue":"5","key":"620_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1086\/511310","volume":"195","author":"W Schul","year":"2007","unstructured":"Schul W, Liu W, Xu H, Flamand M, Vasudevan SG. A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. J Infect Dis. 2007;195(5):665\u201374.","journal-title":"J Infect Dis"},{"issue":"4","key":"620_CR13","doi-asserted-by":"publisher","first-page":"e2116","DOI":"10.1371\/journal.pntd.0002116","volume":"7","author":"JJ Waggoner","year":"2013","unstructured":"Waggoner JJ, Abeynayake J, Sahoo MK, Gresh L, Tellez Y, Gonzalezk BG, Pierro AM, Gaibani P, Guo FP, et al. Single-reaction, multiplex, real-time RT-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis. 2013;7(4):e2116.","journal-title":"PLoS Negl Trop Dis"},{"key":"620_CR14","first-page":"1","volume":"2013","author":"KH Sellahewa","year":"2013","unstructured":"Sellahewa KH. Pathogenesis of dengue haemorrhagic fever and its impact on case management. ISRN Infect Dis. 2013;2013:1\u20136.","journal-title":"ISRN Infect Dis"},{"issue":"10","key":"620_CR15","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1086\/587699","volume":"197","author":"S Ubol","year":"2008","unstructured":"Ubol S, Masrinoul P, Chaijaruwanich J, Kalayanarooj S, Charoensirisuthikul T, Kasisith J. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. J Infect Dis. 2008;197(10):1459\u201367.","journal-title":"J Infect Dis"},{"issue":"6","key":"620_CR16","doi-asserted-by":"publisher","first-page":"e11267","DOI":"10.1371\/journal.pone.0011267","volume":"5","author":"ALV Gomes","year":"2010","unstructured":"Gomes ALV, Wee LJK, Khan AM, Gil LHGV, Marques ETA, Calzavara-Silva CE, Tan TW. Classification of dengue fever patients based on gene expression data using support vector machines. PLoS One. 2010;5(6):e11267.","journal-title":"PLoS One"},{"issue":"2","key":"620_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.4269\/ajtmh.2012.11-0469","volume":"86","author":"AR Brasier","year":"2012","unstructured":"Brasier AR, Ju H, Garcia J, Spratt HM, Victor SS, Forshey BM, Halsey ES, Comach G, Sierra G, et al. A three-component biomarker panel for prediction of dengue hemorrhagic fever. Am J Trop Med Hyg. 2012;86(2):341\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"620_CR18","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1086\/517807","volume":"177","author":"DB Bethell","year":"1998","unstructured":"Bethell DB, Flobbe K, Xuan C, Phuong T, Day NPJ, Phuong PT, Buurman WA, Cardosa MJ, White NJ, Kwiatkowski D. Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis. 1998;177(3):778\u201382.","journal-title":"J Infect Dis"},{"issue":"1","key":"620_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/1471-2334-13-341","volume":"13","author":"GN Malavige","year":"2013","unstructured":"Malavige GN, Gomes L, Alles L, Chang T, Salimi M, Fernando S, Nanayakkara KDL, Jayaratne SD, Ogg GS. Serum IL-10 as a marker of severe dengue infection. BMC Infect Dis. 2013;13(1):341.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"620_CR20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1038\/ng.960","volume":"43","author":"CC Khor","year":"2011","unstructured":"Khor CC, Chau TNB, Pang J, Davila S, Long HT, Ong RT, Dunstan SJ, Wills B, Farrar J, Van Tram T, et al. Genome-wide association study identifies susceptibility loci for dengue shock syndrome at MICB and PLCE1. Nat Genet. 2011;43(11):1139\u201341.","journal-title":"Nat Genet"},{"issue":"3","key":"620_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.7150\/ijms.13996","volume":"13","author":"X Ouyang","year":"2016","unstructured":"Ouyang X, Jiang X, Gu D, Zhang Y, Kong SK, Jiang C, Xie W. Dysregulated serum miRNA profile and promising biomarkers in dengue-infected patients. Int J Med Sci. 2016;13(3):195\u2013205.","journal-title":"Int J Med Sci"},{"issue":"4","key":"620_CR22","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/0004563215604001","volume":"53","author":"PA Tambyah","year":"2016","unstructured":"Tambyah PA, Ching CS, Sepramaniam S, Ali JM, Armugam A, Jeyaseelan K. microRNA expression in blood of dengue patients. Ann Clin Biochem. 2016;53(4):466\u201376. https:\/\/doi.org\/10.1177\/0004563215604001.","journal-title":"Ann Clin Biochem"},{"issue":"3","key":"620_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3892\/mmr.2013.1288","volume":"7","author":"Y Qi","year":"2013","unstructured":"Qi Y, Li Y, Zhang L, Huang J. microRNA expression profiling and bioinformatic analysis of dengue virus-infected peripheral blood mononuclear cells. Mol Med Rep. 2013;7(3):791\u20138. 24.","journal-title":"Mol Med Rep"},{"issue":"8","key":"620_CR24","doi-asserted-by":"publisher","first-page":"e3088","DOI":"10.1371\/journal.pntd.0003088","volume":"8","author":"X Zhu","year":"2014","unstructured":"Zhu X, He Z, Hu Y, Wen W, Lin C, Yu J, Pan J, Li R, Deng H, Liao S, et al. MicroRNA-30e* suppresses dengue virus replication by promoting NF-\u03baB\u2013dependent IFN production. PLoS Negl Trop Dis. 2014;8(8):e3088. https:\/\/doi.org\/10.1371\/journal.pntd.0003088.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"620_CR25","doi-asserted-by":"publisher","first-page":"923","DOI":"10.13005\/bpj\/1449","volume":"11","author":"S Masyeni","year":"2018","unstructured":"Masyeni S, Hadi U, Kuntaman K, Dewi YP. Profiling of microRNA expression within the cells of peripheral blood mononuclear after an infection with serotype-2 of dengue virus: Preliminary Study. Biomed Pharmacol J. 2018;11(2):923\u20137. https:\/\/doi.org\/10.13005\/bpj\/1449.","journal-title":"Biomed Pharmacol J"},{"issue":"4","key":"620_CR26","first-page":"366","volume":"69","author":"RF Chen","year":"2014","unstructured":"Chen RF, Yang KD, Lee IK, Liu JW, Huang CH, Lin CY, Chen YH, Chen CL, Wang L. Augmented miR-150 expression associated with depressed SOCS1 expression involved in dengue haemorrhagic fever. J Inf Secur. 2014;69(4):366\u201374.","journal-title":"J Inf Secur"},{"issue":"28","key":"620_CR27","doi-asserted-by":"publisher","first-page":"20592","DOI":"10.1074\/jbc.M113.472183","volume":"288","author":"DS Ghorpade","year":"2013","unstructured":"Ghorpade DS, Holla S, Sinha AY, Alagesan SK, Balaji KN. Nitric oxide and KLF4 protein epigenetically modify class II transactivator to repress major histocompatibility complex II expression during Mycobacterium bovis bacillus Calmette-Guerin infection. J Biol Chem. 2013;288(28):20592\u2013606.","journal-title":"J Biol Chem"},{"issue":"7","key":"620_CR28","doi-asserted-by":"publisher","first-page":"14647","DOI":"10.3390\/ijms140714647","volume":"14","author":"S Morita","year":"2013","unstructured":"Morita S, Horii T, Kimura M, Ochiya T, Tajima S, Hatada I. miR-29 represses the activities of DNA methyltransferases and DNA demethylases. Int J Mol Sci. 2013;14(7):14647\u201358. https:\/\/doi.org\/10.3390\/ijms140714647.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"620_CR29","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1002\/pmic.201500035","volume":"15","author":"DL Rowles","year":"2015","unstructured":"Rowles DL, Tsai YC, Greco TM, Lin AE, Li M, Yeh J, Cristea IM. DNA methyltransferase DNMT3A associates with viral proteins and impacts HSV-1 infection. Proteomics. 2015;15(12):1968\u201382.","journal-title":"Proteomics."},{"issue":"11","key":"620_CR30","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1128\/MCB.01714-12","volume":"33","author":"L Goedeke","year":"2013","unstructured":"Goedeke L, Vales-Lara FM, Fenstermaker M, Cirera-Salinas D, Chamorro-Jorganes A, Ram\u00edrez CM, Mattison JA, de Cabo R, Su\u00e1rez Y, Fern\u00e1ndez-Hernando C. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol Cell Biol. 2013;33(11):2339\u201352.","journal-title":"Mol Cell Biol"},{"issue":"5","key":"620_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.chom.2010.10.006","volume":"8","author":"NS Heaton","year":"2010","unstructured":"Heaton NS, Randall G. Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe. 2010;8(5):422\u201332.","journal-title":"Cell Host Microbe"},{"issue":"3","key":"620_CR32","doi-asserted-by":"publisher","first-page":"e92140","DOI":"10.1371\/journal.pone.0092140","volume":"9","author":"S Bocchetta","year":"2014","unstructured":"Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, et al. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection. PLoS One. 2014;9(3):e92140.","journal-title":"PLoS One"},{"issue":"40","key":"620_CR33","doi-asserted-by":"publisher","first-page":"43033","DOI":"10.18632\/oncotarget.5824","volume":"6","author":"Z Sun","year":"2015","unstructured":"Sun Z, Wang Y, Han X, Zhao X, Peng Y, Li Y, Peng M, Song J, Wu K, Sun S, et al. miR-150 inhibits terminal erythroid proliferation and differentiation. Oncotarget. 2015;6(40):43033\u201347.","journal-title":"Oncotarget."},{"issue":"26","key":"620_CR34","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1182\/blood-2015-11-679431","volume":"127","author":"Y Yang","year":"2016","unstructured":"Yang Y, Akada H, Nath D, Hutchison RE, Mohi G. Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm. Blood. 2016;127(26):3410\u201323.","journal-title":"Blood."},{"issue":"12","key":"620_CR35","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1074\/jbc.M114.548651","volume":"289","author":"T Fujiwara","year":"2014","unstructured":"Fujiwara T, Saitoh H, Inoue A, Kobayashi M, Okitsu Y, Katsuoka Y, Fukuhara N, Onishi Y, Ishizawa K, Ichinohasama R, et al. 3-Deazaneplanocin a (DZNep), an inhibitor of S-adenosylmethionine-dependent methyltransferase, promotes erythroid differentiation. J Biol Chem. 2014;289(12):8121\u201334.","journal-title":"J Biol Chem"},{"issue":"4","key":"620_CR36","doi-asserted-by":"publisher","first-page":"e01141","DOI":"10.1128\/mBio.01141-17","volume":"8","author":"JH Arbuckle","year":"2017","unstructured":"Arbuckle JH, Gardina PJ, Gordon DN, Hickman HD, Yewdell JW, Pierson TC, Myers TG, Kristie TM. Inhibitors of the histone methyltransferases EZH2\/1 induce a potent antiviral state and suppress infection by diverse viral pathogens. MBio. 2017;8(4):e01141\u201317.","journal-title":"MBio."},{"issue":"4","key":"620_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2149\/tmh.2014-09","volume":"42","author":"JN Mangione","year":"2014","unstructured":"Mangione JN, Huy NT, Lan NT, Mbanefo EC, Ha TT, Bao LQ, Nga CT, Tuong VV, Dat TV, Thuy TT, et al. The association of cytokines with severe dengue in children. Trop Med Health. 2014;42(4):137\u201344.","journal-title":"Trop Med Health"},{"issue":"40","key":"620_CR38","doi-asserted-by":"publisher","first-page":"7530","DOI":"10.1021\/acs.jafc.6b03615","volume":"64","author":"Y Jia","year":"2016","unstructured":"Jia Y, Ling M, Zhang L, Jiang S, Sha Y, Zhao R. Downregulation of miR-150 expression by DNA hypermethylation is associated with high 2-hydroxy-(4-methylthio) butanoic acid-induced hepatic cholesterol accumulation in nursery piglets. J Agric Food Chem. 2016;64(40):7530\u20139.","journal-title":"J Agric Food Chem"},{"key":"620_CR39","doi-asserted-by":"publisher","unstructured":"Hapugaswatte H, Perera SS, Premaratna R, Seneviratne KN, Jayathilaka N. Expression of inducible nitric oxide synthase, nitric oxide and salivary oxidized LDL as early markers of severe dengue. bioRxiv. 2019:664151. https:\/\/doi.org\/10.1101\/664151.","DOI":"10.1101\/664151"},{"issue":"11","key":"620_CR40","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1002\/jcp.26576","volume":"233","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Zhang Q, Gui L, Cai Y, Deng X, Li C, Guo Q, He X, Huang J. Let-7e inhibits TNF-\u03b1 expression by targeting the methyl transferase EZH2 in DENV2-infected THP-1 cells. J Cell Physiol. 2018;233(11):8605\u201316.","journal-title":"J Cell Physiol"},{"issue":"7078","key":"620_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nature04431","volume":"439","author":"E Vir\u00e9","year":"2006","unstructured":"Vir\u00e9 E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C, Morey L, Van Eynde A, Bernard D, Vanderwinden JM, et al. The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2006;439(7078):871\u20134.","journal-title":"Nature"},{"issue":"2","key":"620_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.yexmp.2015.07.001","volume":"99","author":"J Mor\u00e1n","year":"2015","unstructured":"Mor\u00e1n J, Ram\u00edrez-Mart\u00ednez G, Jim\u00e9nez-Alvarez L, Cruz A, P\u00e9rez-Patrigeon S, Hidalgo A, Orozco L, Mart\u00ednez A, Padilla-Noriega L, Avila-Moreno F, et al. Circulating levels of miR-150 are associated with poorer outcomes of a\/H1N1 infection. Exp Mol Pathol. 2015;99(2):253\u201361.","journal-title":"Exp Mol Pathol"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-0620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12929-020-0620-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-020-0620-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T19:07:48Z","timestamp":1610824068000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-020-0620-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["620"],"URL":"https:\/\/doi.org\/10.1186\/s12929-020-0620-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/19002725","asserted-by":"object"}]},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,18]]},"assertion":[{"value":"2 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance for patient sample collection was obtained from the Ethics Review Committee of the Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka (Reference number-P\/119\/07\/2015). Written patient consent was obtained prior to the sample collection. The patient consent form was obtained from the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25"}}